TWO SIGMA INVESTMENTS, LP - LIXTE BIOTECHNOLOGY HLDGS IN ownership

LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXT and the CUSIP is 539319202. A total of 16 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of LIXTE BIOTECHNOLOGY HLDGS IN
ValueSharesWeighting
Q1 2023$20,601
+103.6%
24,901
+25.3%
0.00%
Q4 2022$10,116
-15.7%
19,874
-6.6%
0.00%
Q3 2022$12,000
-7.7%
21,274
+25.5%
0.00%
Q2 2022$13,00016,9480.00%
Other shareholders
LIXTE BIOTECHNOLOGY HLDGS IN shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 99,644$56,0000.07%
SANTA MONICA PARTNERS LP 166,667$93,0000.07%
Virtu Financial LLC 12,784$7,0000.00%
Warberg Asset Management LLC 14,500$8,0000.00%
TWO SIGMA INVESTMENTS, LP 21,274$12,0000.00%
FMR LLC 100$00.00%
WELLS FARGO & COMPANY/MN 51$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 25,794$14,0000.00%
STATE STREET CORP 35,956$20,0000.00%
View complete list of LIXTE BIOTECHNOLOGY HLDGS IN shareholders